Company / Working Capital per Share
MAIA Biotechnology, Inc. Working Capital per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.37
FY2024
5-year range
$0.24 / $1.13
FY2022-FY2024
Trend
+55.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1.13 to $0.37 over the past 2 years.
Based on SEC 10-K filings.
0.37 in FY2024.
Declined from $1.13 to $0.37 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, working capital per share increased 55.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -11.78 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.37 | +55.2% |
| FY2023 | $0.24 | -78.7% |
| FY2022 | $1.13 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026